-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

622.O1.6 622. Lymphomas: Translational – Non-Genetic: Illuminating the Tumor Microenvironment and Immune Landscape in Lymphoma

Symposia: Lymphomas: Translational–Non-Genetic Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Hodgkin lymphoma, Translational Research, Lymphomas, non-Hodgkin lymphoma, Diseases, Lymphoid Malignancies, emerging technologies, Technology and Procedures, omics technologies
Saturday, December 9, 2023: 2:00 PM-3:30 PM
Seaport Ballroom ABCD (Manchester Grand Hyatt San Diego)
Moderators:
Santosha A Vardhana, MD, PhD, Memorial Sloan Kettering Cancer Center and Leandro Cerchietti, MD, Weill Cornell Medical College
Disclosures:
Vardhana: Immunai: Consultancy; Koch Disruptive Technologies: Consultancy.
This Session Will Provide New Insights into the Composition, Biology, and Prognostic Significance of the Tumor Microenvironment in Lymphoid Malignancies, Tevealed by Cutting-Edge Single-Cell, Spatial, and ctDNA Sequencing and Imaging Technologies.
2:00 PM

Vignesh Shanmugam, MD1,2, Neriman Tokcan, PhD3,4*, Daniel Chafamo5*, Sean Sullivan4*, Haley Martin6*, Gail A Newton, PhD6*, Mehdi Borji, MS4*, Naeem Nadaf4*, Irving Barrera4*, Dylan Cable, PhD4,7*, Jackson Weir4,8*, Orr Ashenberg, PhD5*, Caroline Uhler, PhD4,9,10*, Geraldine Pinkus, MD1*, Scott Rodig, MD, PhD1, Margaret A. Shipp, MD11, Evan Macosko, MD, PhD4,12*, Abner Louissaint, MD, PhD13*, Fei Chen, PhD4,14* and Todd R. Golub, MD4,15,16*

1Department of Pathology, Brigham and Women's Hospital, Boston, MA
2Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA
3Department of Mathematics, University of Massachusetts Boston, Boston, MA
4Broad Institute of MIT and Harvard, Cambridge, MA
5Klarman Cell Observatory, Broad Institute of MIT and Harvard, Cambridge, MA
6Department of Pathology, Massachusetts General Hospital, Boston, MA
7Department of Electrical Engineering and Computer Science, Massachusetts Institute of Technology, Cambridge, MA
8Biological and Biomedical Sciences Program, Harvard University, Cambridge, MA
9Laboratory for Information & Decision Systems, Massachusetts Institute of Technology, Cambridge, MA
10Institute for Data, Systems, and Society, Massachusetts Institute of Technology, Cambridge, MA
11Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
12Department of Psychiatry, Massachusetts General Hospital, Boston, MA
13Massachusetts General Hospital, Boston, MA
14Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA
15Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA
16Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, MA

2:15 PM

Ilja Kalashnikov, MD1*, Veronica Russell2*, Panu Kovanen, MD, PhD3*, Johannes Dunkel, MD, PhD3*, Marja-Liisa Karjalainen-Lindsberg, MD, PhD3*, Annika Pasanen, MD, PhD4*, Rachel Kositsky, PhD5*, Sarah L. Ondrejka, DO6, Tanu Goyal, MD7*, Eric D. Hsi, MD8, Mette Ølgod Pedersen, MD9*, Anne Ortved Gang, MD10*, Magdalena Czader, MD, PhD11*, Jiehao Zhou12*, Mina Xu, MD13*, Nathan Paulson13*, Jean L. Koff, MD, MSc14, Andrew G Evans, MD, PhD15*, Yasodha Natkunam, MD, PhD16, Ridas Juskevicius, MD17, Abner Louissaint, MD, PhD18*, Elizabeth Thacker19*, Tushar Dave2*, Cassandra L. Love2, Chad M McCall, MD, PhD20*, Choon Kiat Ong, PhD, BSc21*, Michael Churnetski, BS22*, Haley Martin23*, Jennifer R. Chapman-Fredricks, MD24*, Javeed Iqbal, PhD, MSc25*, Amy Chadburn, MD26, Payal Sojitra27*, Amir Behdad, MD28*, William Choi, MBBS, MRCP29, Jie Xu, MD PhD30*, Emily F. Ferguson Mason, MD, PhD17*, Kikkeri N Naresh31, Yuri D. Fedoriw, MD32*, Dina Sameh Soliman, MD, MBBS, MSc33, Sandeep Dave, M.D.34* and Sirpa Leppä, Professor1,4

1University of Helsinki, Helsinki, Finland
2Duke University, Durham, NC
3Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
5AstraZeneca, Waltham, MA
6Department of Laboratory Medicine, Cleveland Clinic, Cleveland, OH
7Cleveland Clinic, Cleveland, OH
8Department of Pathology, Wake Forest Baptist Medical Center, Winston Salem, NC
9Herlev hospital, Herlev, DNK
10Copenhagen University Hospital, Herlev, Denmark
11Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, IN
12Indiana University, Indianapolis, IN
13Yale University, New Haven, CT
14Winship Cancer Institute, Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
15Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY
16Stanford Univ. Med. Ctr., Stanford, CA
17Vanderbilt University Medical Center, Nashville, TN
18Massachusetts General Hospital, Boston, MA
19Data Driven Bioscience, Durham, NC
20Carolinas Pathology Group, Charlotte, NC
21National Cancer Centre Singapore, Singapore, Singapore, SGP
22Emory University, Atlanta, GA
23Department of Pathology, Massachusetts General Hospital, Boston, MA
24University of Miami Miller School of Medicine, Miami, FL
25Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE
26Department of Pathology and Laboratory Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY
27Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ
28Regents of The University of Michigan, Ann Arbor, MI
29Tuen Mun Hospital, Happy Valley, NA, HKG
30Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX
31Fred Hutchinson Cancer Center, Seattle, WA
32University of North Carolina, Chapel Hill, NC
33HMC-Qatar, Doha, QAT
34Duke University Medical Center, Durham, NC

2:30 PM

Stefan K. Alig, MD1, Mohammad Shahrokh Esfahani, PhD1*, Andrea Garofalo1, Michael Yu Li, BS2*, Cédric Rossi, MD, PhD3,4, Timothy Flerlage, MD5*, Jamie E. Flerlage, MD, MS6, Ragini Adams7*, Michael S. Binkley, MD, MS8*, Navika Shukla, MD1, Michael Jin, BS1*, Mari Olsen1*, Adele Telenius, MPhil, BSc2*, Jurik A Mutter, PhD1*, Joseph G Schroers-Martin, MD1, Brian J. Sworder, MD, PhD9, Shinya Rai, MD, PhD2*, Daniel King, MD1*, Andre Schultz, PhD1*, Jan Lukas Bögeholz, MD1*, Shengqin Su10*, Karan R Kathuria1*, Chih Long Liu1*, Xiaoman Kang1*, Deanna M. Langfitt, PhD11*, Kristine Faye Pobre-Piza12*, Feng Tian1*, Maya J. Strohband1*, Valeria Spina13*, Thomas Tousseyn14*, Lieselot Buedts15*, Luc-Matthieu Fornecker, MD, PhD16*, Sharon M. Castellino, MD, MSc17, Ranjana H. Advani, MD1, Davide Rossi13, Ryan C Lynch, MD18, Herve Ghesquieres, MD, PhD19*, Olivier Casasnovas, MD20*, David M. Kurtz, MD, PhD1, Lianna J. Marks, MD21, Michael P. Link, MD21, Marc Andre, MD22*, Peter Vandenberghe, MD, PhD23, Christian Steidl, MD, PhD2, Maximilian Diehn, MD, PhD24* and Ash A. Alizadeh, MD, PhD1

1Department of Medicine, Divisions of Oncology and Hematology, Stanford University, Stanford, CA
2Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada
3Stanford University, Stanford, CA
4CHU Dijon, Dijon, France
5Department of Oncology, St Jude Children's Research Hospital, Memphis, TN
6Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
7Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Stanford, CA
8Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA
9Division of Oncology, Department of Medicine, Stanford University, Irvine, CA
10Department of Radiation Oncology, Stanford University School of Medicine, Palo Alto, CA
11Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
12Department of Infectious Diseases, St Jude Children's Research Hospital, Memphis, TN
13Oncology Institute of Southern Switzerland, Bellinzona, Switzerland
14Department of Imaging & Pathology, KU Leuven, Leuven, Belgium
15Department of Human Genetics, KU Leuven, Leuven, Belgium
16Hematology Department, Institut De Cancérologie Strasbourg Europe, Strasbourg, France
17Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
18Division of Hematology and Oncology, University of Washington, Seattle, WA
19Centre Hospitalier Lyon Sud, Lyon, France
20Department of Hematology, Centre Hospitalier Universitaire Dijon, Dijon, France
21Department of Pediatrics, Division of Pediatric Hematology and Oncology, Stanford University, Palo Alto, CA
22Department of Hematology, Clinique de Mont-Godinne, Yvoir, Belgium
23Department of Hematology, Department of Human Genetics, University Hospitals Leuven, KU Leuven, Leuven, Belgium
24Department of Radiation Oncology, Stanford University, Stanford, CA

2:45 PM

Matias Autio1,2*, Suvi-Katri Leivonen, PhD1,2, Marja-Liisa Karjalainen-Lindsberg, MD, PhD3*, Teijo Pellinen, PhD4* and Sirpa Leppä, Professor1,2

1University of Helsinki, Helsinki, Finland
2Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
3Department of Pathology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
4Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland

3:00 PM

Kanutte Huse, PhD1,2*, Yngvild Blaker, MD PhD1*, Jillian Frances Wise, PhD1*, Ankush Sharma, PhD1*, Leo Meriranta, MD3*, Kathrine Thuestad Isaksen, MD1,2*, Ivana Spasevska, PhD1,2*, Sigve Nakken, PhD4*, Vera Hilden1,2*, Mette Førsund5*, Sirpa Leppä, Professor3, Erlend B. Smeland5*, Harald Holte, MD, PhD6 and June Helen Myklebust, PhD1,2

1Institute for Cancer Research, Oslo University Hospital, Oslo, Norway
2Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway
3Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
4University of Oslo, Oslo, Norway
5Oslo University Hospital, Oslo, Norway
6Department of Oncology, Oslo University Hospital, Oslo, NOR

3:15 PM

Tobias Wertheimer1,2*, Hosna Baniadam, MSc3*, Stefanie Reisenauer4*, Marcel Pohly5,6*, Lukas Rindlisbacher7*, Minqi Lin7*, Stefanie Kreutmair7*, Susanne Unger8*, Jarno Kivioja, PhD9*, Andreas Moor6*, Burkhard Becher10*, Wolfgang Huber11* and Thorsten Zenz12

1Institute for Experimental Immunology, University of Zurich, Zurich, NY, Switzerland
2Department for Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland
3European Molecular Biology Laboratory, Heidelberg, Germany
4University Hospital Zurich, Zurich, Switzerland
5University Hospital Zurich, Switzerland, Zurich, CHE
6Dep. of Biosystems Science and Eng., ETH Zurich, Zurich, Switzerland
7University of Zurich, Zurich, Switzerland
8University of Zurich, Zurich, AL, CHE
9University Hospital Zurich, Zürich, ZH, CHE
10University of Zurich, Zurich, CHE
11Genome Biology Unit, European Molecular Biology Laboratory, Heidelberg, Germany
12Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland

*signifies non-member of ASH